Rheumatoid Arthritis

SAN DIEGO — Jeffrey A. Sparks, MD, MMSc, spoke with Healio about two “high-impact” presentations from ACR Convergence 2023 that assessed dosing of prednisone for patients with rheumatoid arthritis.

SAN DIEGO — In this video, Healio spoke with Jeffrey A. Sparks, MD, MMSc, results from a study conducted in India assessing the efficacy of treating rheumatoid arthritis with split-doses of methotrexate.

SAN DIEGO — The likelihood of opioid use among patients with autoimmune rheumatic disease has decreased annually by 15% since 2014, according to data presented at ACR Convergence 2023.

SAN DIEGO — Glucocorticoid doses as small as 5 mg per day, in durations as short as 30 days, and a use period as long as 1 year all increase the risk for major adverse cardiac events in rheumatoid arthritis, said a speaker here.

In this episode of Meeting Mic, we bring you Healio’s top headlines from ACR Convergence 2023.

SAN DIEGO — An automated deep learning model accurately identified and predicted joint space narrowing and erosion based on hand radiographs of patients with rheumatoid arthritis, according to data presented at ACR Convergence 2023.

SAN DIEGO — Patients treated with telitacicept demonstrated improvements in American College of Rheumatology response and structural damage in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2023.

As of just a few years ago, early enthusiasm over the apparent interplay between the gut microbiome and the immune system, and that it was driving or exacerbating certain rheumatic diseases, seemed to have all but dried up.

SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a presentation from ACR Convergence 2023 that assessed the impact of diet on patients with rheumatoid arthritis and lupus.

SAN DIEGO — In this video, Kathryn Dao, MD, spoke with Healio about patient-reported outcomes from the ARCTIC REWIND study presented at ACR Convergence 2023.